Product Information
SYNJARDY XR 12.5-1,000 MG TAB is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $5.5969 per EA under NDC 00597030093. Its NADAC has been published 449 times since Jan 17, 2018.
FDA first approved this application on Dec 9, 2016.
Strength
12.5; 1000 mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597030093
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA208658FDA Approved
12/9/2016
On Market Since
12/10/2016
Pharmacological Classes
Price Statistics
The NADAC for SYNJARDY XR 12.5-1,000 MG TAB has been published 449 times since Jan 17, 2018, and over the history we have for it it has declined 25.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.5969 per EA |
|---|---|
| All-time high | $10.0684 (May 14, 2025) |
| All-time low | $5.5938 (Jan 7, 2026) |
| 52-week high | $10.0628 |
| 52-week low | $5.5938 |
| Median price | $8.7592 |
| Average price | $8.6226 |
| Largest weekly change | -44.4% (Jan 7, 2026) |
| Weeks tracked | 449 |
| Tracking since | Jan 17, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SYNJARDY XR 12.5-1,000 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for SYNJARDY XR 12.5-1,000 MG TAB, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $5.5969 per EA (NDC 00597030093), effective Aug 19, 2026.
How has the price of SYNJARDY XR 12.5-1,000 MG TAB changed over time?
Over the history we have for it, the NADAC for SYNJARDY XR 12.5-1,000 MG TAB has declined 25.1%. It has been tracked across 449 weekly CMS publications since Jan 17, 2018.
What are the highest and lowest recorded NADAC prices for SYNJARDY XR 12.5-1,000 MG TAB?
Since Jan 17, 2018, the NADAC for SYNJARDY XR 12.5-1,000 MG TAB has ranged from a low of $5.5938 (Jan 7, 2026) to a high of $10.0684 (May 14, 2025), with a median of $8.7592 per EA.
Are there cheaper alternatives to SYNJARDY XR 12.5-1,000 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SYNJARDY XR 12.5-1,000 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures SYNJARDY XR 12.5-1,000 MG TAB?
SYNJARDY XR 12.5-1,000 MG TAB (NDC 00597030093) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.